Table 1 Number of women included in first (screening) and second (validation) phases
From: Circulating miRNAs signature on breast cancer: the MCC-Spain project
Group of analysis | First phase | Second phase |
|---|---|---|
Controls | 10 | 131 |
Cases (overall) | 30 | 269 |
Cases detected by screening | 10 | 102 |
Cases detected without screening, free of disease in the follow-up | 10 | 102 |
Cases detected without screening, active disease in the follow-up | 10 | 65 |